Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed

Rapamycin has been used topically to treat facial angiofibromas associated with tuberous sclerosis for more than a decade. In the absence of a commercial form, a large number of formulations have been clinically tested. However, given the great heterogeneity of these studies, particularly with regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Guyader, Guillaume, Do, Bernard, Vieillard, Victoire, Andrieux, Karine, Paul, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694993/
https://www.ncbi.nlm.nih.gov/pubmed/33171735
http://dx.doi.org/10.3390/pharmaceutics12111060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694993/
https://www.ncbi.nlm.nih.gov/pubmed/33171735
http://dx.doi.org/10.3390/pharmaceutics12111060

Ejemplares similares